Literature DB >> 21420364

IgG replacement therapy, no size fits all.

Francisco A Bonilla.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420364     DOI: 10.1016/j.clim.2011.02.020

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  6 in total

Review 1.  Considerations for dosing immunoglobulin in obese patients.

Authors:  J P Hodkinson
Journal:  Clin Exp Immunol       Date:  2017-04-17       Impact factor: 4.330

Review 2.  Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.

Authors:  Richard L Wasserman
Journal:  J Clin Immunol       Date:  2012-07-25       Impact factor: 8.317

3.  Home care use of intravenous and subcutaneous immunoglobulin for primary immunodeficiency in the United States.

Authors:  Faith Huang; Elizabeth Feuille; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2012-09-08       Impact factor: 8.317

4.  Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push.

Authors:  R Shapiro
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

5.  Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study.

Authors:  Fernanda Aimée Nobre; Isabela Garrido da Silva Gonzalez; Raquel Maria Simão; Maria Isabel de Moraes Pinto; Beatriz Tavares Costa-Carvalho
Journal:  BMC Immunol       Date:  2014-06-21       Impact factor: 3.615

6.  Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment.

Authors:  Teresa Espanol; Johan Prevot; Jose Drabwell; Seema Sondhi; Laurence Olding
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.